Femme et Homme
- | Pays :
- Australia
- South Africa
- Germany
- Les 8 autres...
- | Organes : -
- | Spécialités : -
Extrait
This is a phase III multi-centre study in three periods: the first period is a phosphate binder washout for 4 weeks, the second period is an open-label, randomised, parallel group, flexible dose, the third period is a placebo-controlled withdrawal comparing MCI-196 with placebo for 4 weeks.
Critère d'inclusion
- chronic kidney disease ,Hyperphosphatemia